Search results
Results From The WOW.Com Content Network
Like other marijuana stocks, GW Pharmaceuticals (NASDAQ:GWPH) has struggled for the last three months. Despite its U.K.-base of operations, it has behaved similarly to the stocks of its Canadian ...
GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $144.55, moving -1.51% from the previous trading session.
Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) tumbled nearly 5% in after-hours trading Wednesday, after the drug maker announced negative results with GWP42006 in adult patients with focal ...
GW Pharmaceuticals was founded in 1998 by doctors Geoffrey Guy and Brian Whittle. That year, they obtained a cultivation license from the United Kingdom Home Office and the MHRA, allowing the company to cultivate, possess and supply cannabis to conduct scientific research concerning medical cannabis.
In finance, a growth stock is a stock of a company that generates substantial and sustainable positive cash flow and whose revenues and earnings are expected to increase at a faster rate than the average company within the same industry. [1]
In the latest trading session, GW Pharmaceuticals PLC (GWPH) closed at $168.14, marking a -0.26% move from the previous day.
The New York Stock Exchange on Wall Street, the world's largest stock exchange in terms of total market capitalization of its listed companies, as of 2010 [1]. Market capitalization, sometimes referred to as market cap, is the total value of a publicly traded company's outstanding common shares owned by stockholders.
GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $143.95, moving -1.32% from the previous trading session.